Livforsakringsbolaget Skandia Omsesidigt Acquires New Position in CME Group Inc. $CME

Livforsakringsbolaget Skandia Omsesidigt bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 2,256 shares of the financial services provider’s stock, valued at approximately $498,000.

A number of other hedge funds also recently added to or reduced their stakes in CME. Whipplewood Advisors LLC increased its position in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares during the period. Elkhorn Partners Limited Partnership acquired a new position in CME Group during the 4th quarter worth $27,000. Hilton Head Capital Partners LLC purchased a new stake in CME Group during the 4th quarter worth about $28,000. Legacy Wealth Managment LLC ID increased its holdings in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares during the period. Finally, Main Street Group LTD acquired a new stake in CME Group in the 1st quarter valued at about $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CME shares. Weiss Ratings cut CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Raymond James Financial reaffirmed an “outperform” rating and issued a $320.00 target price on shares of CME Group in a report on Thursday, July 2nd. The Goldman Sachs Group decreased their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday, June 30th. Finally, Deutsche Bank Aktiengesellschaft cut shares of CME Group from a “buy” rating to a “hold” rating and lowered their price target for the stock from $286.00 to $270.00 in a report on Wednesday, August 19th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $288.56.

CME Group Stock Performance

NASDAQ CME opened at $285.80 on Friday. The firm has a market cap of $102.77 billion, a P/E ratio of 24.24, a P/E/G ratio of 3.40 and a beta of 0.23. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The business’s 50-day moving average price is $253.80 and its 200 day moving average price is $279.13. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same period last year, the firm earned $2.96 EPS. On average, equities research analysts expect that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction on Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.